Agency
National Institute of Health (NIH)
Institute
National Institute of Mental Health (NIMH)
Type
Research and Development Contracts (N01)
Project #
N01MH070010-009
Application #
6828772
Study Section
Project Start
Project End
Budget Start
Budget End
Support Year
Fiscal Year
2003
Total Cost
Indirect Cost
Name
University of California Los Angeles
Department
Type
DUNS #
City
State
Country
Zip Code
Levine, S Z; Kodesh, A; Goldberg, Y et al. (2016) Initial severity and efficacy of risperidone in autism: Results from the RUPP trial. Eur Psychiatry 32:16-20
Aman, Michael; Rettiganti, Mallikarjuna; Nagaraja, Haikady N et al. (2015) Tolerability, Safety, and Benefits of Risperidone in Children and Adolescents with Autism: 21-Month Follow-up After 8-Week Placebo-Controlled Trial. J Child Adolesc Psychopharmacol 25:482-93
Hallett, Victoria; Lecavalier, Luc; Sukhodolsky, Denis G et al. (2013) Exploring the manifestations of anxiety in children with autism spectrum disorders. J Autism Dev Disord 43:2341-52
Nurmi, E L; Spilman, S L; Whelan, F et al. (2013) Moderation of antipsychotic-induced weight gain by energy balance gene variants in the RUPP autism network risperidone studies. Transl Psychiatry 3:e274
Scahill, Lawrence; Hallett, Victoria; Aman, Michael G et al. (2013) Brief Report: social disability in autism spectrum disorder: results from Research Units on Pediatric Psychopharmacology (RUPP) Autism Network trials. J Autism Dev Disord 43:739-46
Tobiasova, Zuzana; van der Lingen, Klaas H B; Scahill, Lawrence et al. (2011) Risperidone-related improvement of irritability in children with autism is not associated with changes in serum of epidermal growth factor and interleukin-13. J Child Adolesc Psychopharmacol 21:555-64
Arnold, L Eugene; Farmer, Cristan; Kraemer, Helena Chmura et al. (2010) Moderators, mediators, and other predictors of risperidone response in children with autistic disorder and irritability. J Child Adolesc Psychopharmacol 20:83-93
Nikolov, Roumen N; Bearss, Karen E; Lettinga, Jelle et al. (2009) Gastrointestinal symptoms in a sample of children with pervasive developmental disorders. J Autism Dev Disord 39:405-13
Sukhodolsky, Denis G; Scahill, Lawrence; Gadow, Kenneth D et al. (2008) Parent-rated anxiety symptoms in children with pervasive developmental disorders: frequency and association with core autism symptoms and cognitive functioning. J Abnorm Child Psychol 36:117-28
Anderson, George M; Scahill, Lawrence; McCracken, James T et al. (2007) Effects of short- and long-term risperidone treatment on prolactin levels in children with autism. Biol Psychiatry 61:545-50

Showing the most recent 10 out of 14 publications